2014
DOI: 10.3892/or.2014.3499
|View full text |Cite
|
Sign up to set email alerts
|

Possible involvement of tumor-producing VEGF-A in the recruitment of lymphatic endothelial progenitor cells from bone marrow

Abstract: Lymphatic metastasis of human malignant adenocarcinomas is a critical determinant of prognosis. Lymphangiogenesis, the growth of lymphatic vessels, is closely involved in lymphatic metastasis. However, the mechanisms of tumor lymphangiogenesis are not clearly understood. In a previous study, we showed that human gastric cancer MKN45 cells organize neighboring lymphatic vessels via recruitment of bone marrow-derived lymphatic endothelial progenitor cells in a nude mouse xenograft model. The present results also… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
22
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(26 citation statements)
references
References 32 publications
4
22
0
Order By: Relevance
“…Despite multiple reports demonstrating integration of lymphatic progenitors into preexisting lymphatic vessels [12,15,29] and their role in increasing the number of these vessels [25,32], the evidence for impact of progenitors on lymphatic function is still very limited. Specifically, neither endogenous nor exogenous M-LECP were shown to directly affect tumor growth and metastasis.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite multiple reports demonstrating integration of lymphatic progenitors into preexisting lymphatic vessels [12,15,29] and their role in increasing the number of these vessels [25,32], the evidence for impact of progenitors on lymphatic function is still very limited. Specifically, neither endogenous nor exogenous M-LECP were shown to directly affect tumor growth and metastasis.…”
Section: Resultsmentioning
confidence: 99%
“…Such pro-lymphatic reprogramming has been shown for human monocytes isolated from peripheral or cord blood [24,27], human pluripotent stem cell lines [25], mouse embryonic cells [28], mouse BM-derived CD11b + and mononuclear cells [13,16,29], mouse and human mesenchymal stem cells [30] and adipose-derived stem cells [31]. The main criteria for defining differentiated cells as LECP are as follows: 1) expression of specific LEC markers [16,24,25,27]; 2) acquisition of an endothelial-specific cobblestone morphology and/or ability to form tubes when grown in matrigel [16]; 3) demonstrated function in vivo evidenced by integration into lymphatic vessels [12,15,22] and a statistically significant increase in lymphatic vessel density (LVD) in inflammatory and tissue remodeling models [24,25,32]; and 4) evidence for enhanced functionality of new lymphatics such as improved relief from lymphedema [32] and an accelerated rate of healing wounds [25].…”
Section: Introductionmentioning
confidence: 99%
“…In presence of PRDM16, Myf5 + precursor populations acquire brown fat characteristics specific for “classical” brown adipocytes (52). On the other hand, PRDM16 can also influence the fate of Myf5 − precursors present mostly in the white adipocytes to acquire brown-like phenotype expressing “beige-specific” markers (53). We observed significant enrichment of both classical BAT progenitors including Myf5 and Oplah, as well as the beige adipocyte-specific markers Cd137 and Tbx1 during xenograft development, suggesting that both populations increase UCP1 expression as well as contribute to breast tumor development.…”
Section: Discussionmentioning
confidence: 99%
“…It has been well demonstrated that breast tumor cells recruit BM-MSCs, hematopoietic cells including macrophages, as well as many other cell types from the host to promote its growth (5354). Since substantial amount of beige adipose markers of host origin was found in the xenografts, we have been examining whether they were recruited from the microenvironment or from distant sites of the host.…”
Section: Discussionmentioning
confidence: 99%
“…VEGF-A is considered as a molecule that stimulates angiogenesis, mostly via VEGF receptor 2, but also has some potential to stimulate some forms of lymphangiogenesis, especially in inflammation or tumor growth. VEGF-A acts indirectly via macrophages, stimulating the production of VEGF-C and VEGF-D, but it may also directly trigger the expression of Lyve-1 in bone marrow-derived lymphatic endothelial progenitor cells in vitro [35,36]. Overexpression of VEGF-A 164 leads to the formation of giant lymphatic vessels in the mouse ear [37].…”
Section: Discussionmentioning
confidence: 99%